PURE Bioscience Q2 net sales up 20% YoY to $391K; net loss narrows to $798K

PURE BIOSCIENCE, INC.

2025-Q2 EPS reported -$0.01 revenue$946,000

Net product sales $391K for fiscal Q2 ended Jan 31, 2025, vs $325K a year ago (+20%).
Net loss $798K vs $1,002K in prior-year quarter; loss per share unchanged at ($0.01).
SG&A expenses fell $194K due to reductions in personnel, professional fees, and stock comp.
Company advanced dairy membrane solutions to full-scale in-plant pilots with a large distribution partner.
Pilot data shows benefits in water/energy savings, fouling removal, and reduced downtime for dairy ops.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.